Tag: AIL
Aurigene Pharmaceutical introduces Aurigene.AI, an AIML assisted drug discovery platform
AI is an end-to-end solution for small molecule drug discovery combining AI and ML capabilities with Aurigene's core expertise in synthesizing and testing the molecules in vitro and in vivo
Digital interventions revolutionizing enzyme engineering
Artificial Intelligence and Machine Learning are extremely critical for leapfrogging the traditional enzyme evolution process, writes Naveen Kulkarni, CEO, Quantumzyme